🎁 💸 Warren Buffett's Top Picks Are Up +49.1%. Copy Them to Your Watchlist – For FreeCopy Portfolio

Centene's (CNC) Q1 Earnings, Revenues Beat Estimates

Published 04/25/2017, 07:31 AM
Updated 07/09/2023, 06:31 AM
AAPL
-
CNC
-

Centene Corp. (NYSE:CNC) is a well diversified, multi-national healthcare company that has been provides a set of services to the government sponsored healthcare programs since 1954.

The Wisconsin-based company has grown substantially in the last three years through acquisitions, partnerships and alliances. The company’s operating performance has been improving consistently over last few years. Financial liquidity has supported the company’s inorganic growth initiatives that have been the main revenue driver till date. Continuous focus on maximizing shareholders value has always made the stock lucrative to investors.

However, Centene suffers from rising level of debts. Consistently surging expenses also remain a major threat for the company. Moreover, Donald Trump’s decision to repeal former President Barrack Obama's Affordable Care Act (ACA), that has casted an air of uncertainty on the medical sector, also remains a major headwind for this company.

Centene has a decent history when it comes to earnings as the company has beaten estimates in three of the last four quarters, making for an average surprise of 7%.

Currently, Centene holds a Zacks Rank #3 (Hold), but that could definitely change following its earnings report which was just released. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

We have highlighted some of the key stats from this just-revealed announcement below:

Earnings: Centene beats on earnings. Our consensus called for EPS of $1.06, and the company reported adjusted diluted EPS of $1.12.

Revenue: Operating revenues beat our estimate. Our consensus called for revenues of $11.4 billion, and the company reported revenues of $11.7 billion.

Centene Corporation Price and EPS Surprise

Key Stats to Note:

Managed care membership of 12.1 million, rose 5% over 2016.

Health benefits ratio (HBR) was 87.6% in the first quarter of 2017, compared to 88.7% in the prior year quarter.

Total Operating Expenses of $11.5 billion increased 64.3% over the prior year quarter.

Operating cash flow was $1.25 million in the first quarter of 2017, compared to only $196 million in the last year quarter.

For 2017, Centene expects adjusted earnings per diluted share to be in the range of $4.50- $4.90. Total revenues are expected to be in the range of $46 billion to $46.8 billion.

Check back later for our full write up on this Centene earnings report later!

More Stock News: This Is Bigger than the iPhone!

It could become the mother of all technological revolutions. Apple (NASDAQ:AAPL) sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.

Zacks has just released a Special Report that spotlights this fast-emerging
phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020. Click here for the 6 trades >>



Centene Corporation (CNC): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.